These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37995838)

  • 1. Ternary Dry Powder Agglomerate Inhalation Formulation of Melatonin With Air Jet Mixing to Improve In Vitro And In Vivo Performance.
    Zhang Q; Kou S; Cui Y; Dong J; Ye Y; Wang Y; Lu R; Li X; Nie Y; Shi K; Chen F; Hall P; Chen X; Wang Z; Jiang X
    J Pharm Sci; 2024 Feb; 113(2):434-444. PubMed ID: 37995838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation into the Manufacture and Properties of Inhalable High-Dose Dry Powders Produced by Comilling API and Lactose with Magnesium Stearate.
    Lau M; Young PM; Traini D
    AAPS PharmSciTech; 2017 Aug; 18(6):2248-2259. PubMed ID: 28070849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of dispersion enhancer selection in the development of novel tratinterol hydrochloride dry powder inhalation formulations.
    Liu T; Tong S; Liao Q; Pan L; Cheng M; Rantanen J; Cun D; Yang M
    Int J Pharm; 2023 Mar; 635():122702. PubMed ID: 36773729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.
    Le VN; Robins E; Flament MP
    Eur J Pharm Biopharm; 2012 Apr; 80(3):596-603. PubMed ID: 22198291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the influence of magnesium stearate content and mixing modality on the rheological properties and in vitro aerosolization of dry powder inhaler.
    Li J; Ma S; He X; Sun Y; Zhang X; Guan J; Mao S
    Int J Pharm; 2023 Jul; 642():123179. PubMed ID: 37364785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Air-Jet Dry Powder Insufflator for High-Efficiency Aerosol Delivery to Rats.
    Pangeni R; Hassan AAM; Farkas D; Sudarjat H; Longest W; Hindle M; Xu Q
    Mol Pharm; 2023 Apr; 20(4):2207-2216. PubMed ID: 36938947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-milled API-lactose systems for inhalation therapy: impact of magnesium stearate on physico-chemical stability and aerosolization performance.
    Lau M; Young PM; Traini D
    Drug Dev Ind Pharm; 2017 Jun; 43(6):980-988. PubMed ID: 28122460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of lactose carrier on the content homogeneity and dispersibility of beclomethasone dipropionate from dry powder aerosols.
    Zeng XM; Pandhal KH; Martin GP
    Int J Pharm; 2000 Mar; 197(1-2):41-52. PubMed ID: 10704792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous Particle Size Reduction and Homogeneous Mixing to Produce Combinational Powder Formulations for Inhalation by the Single-Step Co-Jet Milling.
    Ling J; Mangal S; Park H; Wang S; Cavallaro A; Zhou QT
    J Pharm Sci; 2019 Sep; 108(9):3146-3151. PubMed ID: 31112716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial Development of an Air-Jet Dry Powder Inhaler for Rapid Delivery of Pharmaceutical Aerosols to Infants.
    Howe C; Hindle M; Bonasera S; Rani V; Longest PW
    J Aerosol Med Pulm Drug Deliv; 2021 Feb; 34(1):57-70. PubMed ID: 32758026
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of magnesium stearate surface coating method on the aerosol performance and permeability of micronized fluticasone propionate.
    Kumar V; Sethi B; Yanez E; Leung DH; Ghanwatkar YY; Cheong J; Tso J; Narang AS; Nagapudi K; Mahato RI
    Int J Pharm; 2022 Mar; 615():121470. PubMed ID: 35041913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cohesive-adhesive balances in dry powder inhaler formulations II: influence on fine particle delivery characteristics.
    Begat P; Morton DA; Staniforth JN; Price R
    Pharm Res; 2004 Oct; 21(10):1826-33. PubMed ID: 15553229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixing of dry powders for inhalation: A review.
    Spahn JE; Zhang F; Smyth HDC
    Int J Pharm; 2022 May; 619():121736. PubMed ID: 35405281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing Aerosolization Using Computational Fluid Dynamics in a Pediatric Air-Jet Dry Powder Inhaler.
    Bass K; Farkas D; Longest W
    AAPS PharmSciTech; 2019 Nov; 20(8):329. PubMed ID: 31676991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dispersibility of lactose fines as compared to API in dry powders for inhalation.
    Thalberg K; Åslund S; Skogevall M; Andersson P
    Int J Pharm; 2016 May; 504(1-2):27-38. PubMed ID: 26965200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
    Jetzer MW; Schneider M; Morrical BD; Imanidis G
    J Pharm Sci; 2018 Apr; 107(4):984-998. PubMed ID: 29247741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Influence of Relative Humidity and Storage Conditions on the Physico-chemical Properties of Inhalation Grade Fine Lactose.
    Stankovic-Brandl M; Zellnitz S; Wirnsberger P; Kobler M; Paudel A
    AAPS PharmSciTech; 2021 Nov; 23(1):1. PubMed ID: 34791545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO; Molokhia AM; Elsayed MM
    Eur J Pharm Biopharm; 2015 Oct; 96():291-303. PubMed ID: 26275831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dry powder inhalers: a brief overview of the drug detachment techniques.
    Mehta PP
    Ther Deliv; 2020 Mar; 11(3):139-143. PubMed ID: 31914863
    [No Abstract]   [Full Text] [Related]  

  • 20. Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers.
    Lucas P; Anderson K; Staniforth JN
    Pharm Res; 1998 Apr; 15(4):562-9. PubMed ID: 9587952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.